Dolutegravir Sodium and Rilpivirine Hydrochloride and Rucaparib Camsylate
Determining the interaction of Dolutegravir Sodium and Rilpivirine Hydrochloride and Rucaparib Camsylate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Rucaparib may increase the blood levels and effects of rilpivirine. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with rucaparib may increase the plasma concentrations and the risk of adverse effects of drugs that are substrates of CYP450 3A4. The proposed mechanism is decreased clearance due to rucaparib-mediated inhibition of CYP450 3A4. In a clinical study, rucaparib increased midazolam Cmax and AUC by 1.13- and 1.38-fold, respectively.
MANAGEMENT: Caution is advised if rucaparib is used concomitantly with drugs that are substrates of CYP450 3A4, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring should be considered whenever rucaparib is added to or withdrawn from therapy with these drugs. Patients should be monitored for the development of adverse effects.
- EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring. Available from: URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000366.jsp&mid=WC0b01ac058067c852" ([2013 - ]):
Generic Name: dolutegravir / rilpivirine
Brand name: Juluca
Synonyms: Dolutegravir and rilpivirine, Dolutegravir and Rilpivirine
Generic Name: rucaparib
Brand name: Rubraca
Synonyms: Rucaparib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir Sodium and Rilpivirine Hydrochloride-Ruconest
- Dolutegravir Sodium and Rilpivirine Hydrochloride-Rufinamide
- Dolutegravir Sodium and Rilpivirine Hydrochloride-Rufinamide Oral Suspension
- Dolutegravir Sodium and Rilpivirine Hydrochloride-Rufinamide Tablets
- Dolutegravir Sodium and Rilpivirine Hydrochloride-Rulox
- Dolutegravir Sodium and Rilpivirine Hydrochloride-Rum-K
- Rucaparib Camsylate-Dom-Etoposide
- Rucaparib Camsylate-Donatuss DC Syrup
- Rucaparib Camsylate-Donatussin
- Rucaparib Camsylate-Donatussin Drops
- Rucaparib Camsylate-Donepezil
- Rucaparib Camsylate-Donepezil 23 mg Tablets